About Transplantation
Transplantation is the procedure in which diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore the normal functions of the body. Organs such as kidneys, liver, heart, lungs, intestine, pancreas, and thymus can be transplanted. Some tissues such as cornea, bones, tendons, heart valves, skin, nerves, and veins can also be replaced with specific alternative tissues. Kidney transplantation is the most common transplantation procedure worldwide, followed by liver and heart transplantations. Cornea and musculoskeletal grafts transplantations are the most common tissue transplantation procedures. The following are the products required during a transplantation procedure: transplantation tissue products, immunosuppressant drugs, and organ preservation solutions.
TechNavio's analysts forecast the Global Transplantation market to grow at a CAGR of 9.36 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of Global Transplantation market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of transplantation tissue products, immunosuppressant drugs, and organ preservation solutions. These products are used for many transplantation procedures including
• Kidney transplantation
• Liver transplantation
• Heart transplantation
• Lung transplantation
• Pancreas transplantation
• Other transplantation
TechNavio's report, the Global Transplantation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Transplantation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Abbott Laboratories
• Arthrex
• Biomet
• Kinetic Concepts
• Medtronic
• Novartis
• Stryker
Other Prominent Vendors
• 21st Century Medicine
• Aastrom Biosciences
• Accord Healthcare
• Acologix
• Actavis
• Advanced Cell Technology
• Allosource
• Arteriocyte
• Astellas Pharma
• Athersys
• Avita Medical
• Bacterin International
• Baxter
• Bellicum Pharmaceuticals
• Bioactive Regenerative Therapeutics
• BioCardia
• BioLife Solutions
• Bio-Rad Laboratories
• BioTime
• Bridge to Life
• Bristol-Myers Squibb
• Cell & Tissue Systems
• Claris Lifesciences
• CONMED
• Cryolife
• Cynata Therapeutics
• Cytomedix
• Cytori Therapeutics
• Dr. F. Köhler Chemie
• Edwards Lifesciences
• Exactech
• Forticell Bioscience
• GE Healthcare
• Genzyme
• Geron
• GlaxoSmithKline
• Harvard Apparatus Regenerative Technologies
• HeartWare
• Histogenics
• Humacyte
• F. Hoffmann-La Roche
• Integra Lifescience
• InVivo Therapeutics
• Johnson & Johnson
• Kensey Nash
• Kiadis Pharma
• Lifeblood Medical
• Lifeline Scientific
• Living Cell Technologies
• Luminex
• MaxCyte
• Mesoblast
• Nanofiber Solutions CTO
• NeoStem
• Neuralstem
• On-X Life Technologies
• Opexa Therapeutics
• Organ Recovery Systems
• Organogenesis
• Osiris Therapeutics
• Osteotech
• Pfizer
• Pluristem Therapeutics
• Preservation Solutions
• Quest Diagnostics
• ReNeuron
• RTI Surgical
• SanBio
• Smith & Nephew
• St. Jude Medical
• StemCells
• Syncardia Systems
• Tengion
• Terumo Medical
• Teva Pharmaceuticals
• Thermo Fischer Scientific
• Thoratec
• Tissue Genesis
• ToleroTech
• TransMedics
• Veloxis Pharmaceuticals
• ViaCyte
• Xvivo Perfusion
• Zimmer
Market Driver
• Increased Incidence of Organ Failure
• For a full, detailed list, view our report
Market Challenge
• Transplant Rejection
• For a full, detailed list, view our report
Market Trend
• Increased Government and NGO Initiatives
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview
06.1 Organ Transplants Performed in Americas
06.2 Organ Transplants Performed in Europe Region
06.3 Organ Transplants Performed in APAC Region
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Application
09. Market Segmentation by Product Type
09.1 Global Transplantation Tissue Products Market
09.1.1 Market Size and Forecast
09.2 Global Immunosuppressant Drugs Market
09.2.1 Market Size and Forecast
09.3 Global Tissue Typing Technologies and Organ Preservation Solutions Market
09.3.1 Market Size and Forecast
09.4 Global Alternative Technologies Market
09.4.1 Market Size and Forecast
10. Geographical Segmentation
10.1 Transplantation Market in Americas
10.1.1 Market Size and Forecast
10.2 Transplantation Market in EMEA Region
10.2.1 Market Size and Forecast
10.3 Transplantation Market in APAC Region
10.3.1 Market Size and Forecast
11. Key Leading Countries
11.1 US
11.2 UK
11.3 France
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Vendor Analysis 2014
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Abbott Laboratories
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Revenue by Business Segmentation
20.1.6 Revenue Comparison 2011 and 2012
20.1.7 Revenue by Geographical Segmentation
20.1.8 Key Information
20.1.9 SWOT Analysis
20.2 Arthrex
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Product Groups
20.2.4 Key Locations
20.2.5 Recent Developments
20.2.6 SWOT Analysis
20.3 Biomet
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Product Segmentation by Revenue 2014
20.3.4 Product Segmentation by Revenue 2013 and 2014
20.3.5 Geographical Segmentation by Revenue 2014
20.3.6 Business Strategy
20.3.7 Recent Developments
20.3.8 SWOT Analysis
20.4 Kinetic Concepts
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation
20.4.4 Business Segmentation by Revenue 2013
20.4.5 Sales by Geography
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis
20.5 Medtronic
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Business Segmentation by Revenue 2013
20.5.4 Business Segmentation by Revenue 2012 and 2013
20.5.5 Geographical Segmentation by Revenue 2013
20.5.6 Business Strategy
20.5.7 Recent Developments
20.5.8 SWOT Analysis
20.6 Novartis
20.6.1 Key Facts
20.6.2 Business Description
20.6.3 Business Segmentation
20.6.4 Revenue by Business Segmentation
20.6.5 Revenue Comparison 2012 and 2013
20.6.6 Sales by Geography
20.6.7 Business Strategy
20.6.8 Key Developments
20.6.9 SWOT Analysis
20.7 Stryker
20.7.1 Key Facts
20.7.2 Business Overview
20.7.3 Business Segmentation by Revenue 2013
20.7.4 Business Segmentation by Revenue 2012 and 2013
20.7.5 Geographical Segmentation by Revenue 2013
20.7.6 Business Strategy
20.7.7 Recent Developments
20.7.8 SWOT Analysis
21. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Transplant Procedures Performed Americas 2013
Exhibit 3: Transplant Procedures Performed Europe Region 2013
Exhibit 4: Transplant Procedures Performed APAC Region 2013
Exhibit 5: Global Transplantation Market 2014-2019 (US$ billion)
Exhibit 6: Segmentation of Global Transplantation Market by Application
Exhibit 7: Segmentation of Global Transplantation Market by Application 2014
Exhibit 8: Segmentation of Global Transplantation Market by Product Type
Exhibit 9: Segmentation of Global Transplantation Market by Product Type 2014 and 2019
Exhibit 10: Global Transplantation Tissue Products Market 2014-2019 (US$ billion)
Exhibit 11: Global Immunosuppressant Drugs Market 2014-2019 (US$ billion)
Exhibit 12: Global Tissue Typing Technologies and Organ Preservation Solutions Market 2014-2019 (US$ billion)
Exhibit 13: Global Alternative Technologies Market 2014-2019 (US$ billion)
Exhibit 14: Segmentation of Global Transplantation Market by Product Type 2014-2019 (in billion)
Exhibit 15: Segmentation of Global Transplantation Market by Product Type 2014-2019
Exhibit 16: Segmentation of Global Transplantation Market by Geography 2014 and 2019
Exhibit 17: Transplantation Market in Americas 2014-2019 (US$ billion)
Exhibit 18: Transplantation Market in EMEA Region 2014-2019 (US$ billion)
Exhibit 19: Transplantation Market in APAC Region 2014-2019 (US$ billion)
Exhibit 20: Global Transplantation Market Segmentation by Geography 2014-2019 (US$ billion)
Exhibit 21: Global Transplantation Market Segmentation by Geography 2014-2019
Exhibit 22: Abbott Laboratories Inc.: Business Segmentation
Exhibit 23: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
Exhibit 24: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 (US$ million)
Exhibit 25: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
Exhibit 26: Arthrex: Product Groups
Exhibit 27: Arthrex: Key Locations
Exhibit 28: Biomet: Product Segmentation by Revenue 2014
Exhibit 29: Biomet: Product Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 30: Biomet: Geographical Segmentation by Revenue 2014
Exhibit 31: Kinetic Concepts: Business Segmentation 2013
Exhibit 32: Kinetic Concepts: Business Segmentation by Revenue 2013
Exhibit 33: Kinetic Concepts: Sales by Geography 2013
Exhibit 34: Medtronic: Business Segmentation by Revenue 2013
Exhibit 35: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 36: Medtronic: Geographical Segmentation by Revenue 2013
Exhibit 37: Novartis AG: Business Segmentation
Exhibit 38: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 39: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 40: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 41: Stryker: Business Segmentation by Revenue 2013
Exhibit 42: Stryker: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 43: Stryker: Geographical Segmentation by Revenue 2013
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : November 2019
$ 3600
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
